Drug Topics
JULY 28, 2023
Zavegepant (Zavzpret) is the first and only calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray approved by the FDA for acute migraine treatment in adults.
Pharmacy Times
JULY 28, 2023
Author of the book The Journey’s End discusses how extending life at all costs takes away time that patients could be spending with their families during the last moments of their life.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
JULY 28, 2023
A research paper has reported a practical framework suitable for a systematic step-by-step quality by design (QbD) approach for the pharmaceutical development of bilayer tablets. According to the authors, bilayer tablets have been considered one of the best options for the development of fixed-dose combination (FDC) formulations. By delivering active substances, they can avoid incompatibilities in solubility, stability, and therapeutic efficacy in a single dosage form.
Fierce Pharma
JULY 28, 2023
On Monday during a quarterly earnings call, when Biogen CEO Chris Viehbacher was asked about the company’s potential to execute M&A, he randomly offered “we’ve got, I think, about $7.3 billion | Biogen has revealed a proposal to acquire Reata Pharmaceuticals for $7.3 billion. The Texas-based rare disease specialist brings newly approved Skyclarys, the first treatment for the neurologic disorder Friedreich’s ataxia with peak sales potential of $1.5 billion.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
JULY 26, 2023
The Equitable Community Access to Pharmacy Services legislation was introduced earlier this year in the House of Representatives.
Pharmacy Times
JULY 28, 2023
PT staff discusses health outcomes involving SABI, reduced vascular function, and OBA.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmaceutical Technology
JULY 28, 2023
NS Pharma’s candidate would be the first to target Duchenne Muscular Dystrophy (DMD) patients amenable to exon 44 skipping therapy.
Drug Topics
JULY 25, 2023
Radiation therapy was associated with the largest increase, compared to chemotherapy or endocrine therapies.
Pharmacy Times
JULY 28, 2023
The approval of RiVive naloxone hydrochloride nasal spray for nonprescription use provides another tool to help quickly reverse the effects of opioid overdose.
STAT
JULY 28, 2023
Canan Dagdeviren has dedicated her career to creating tools that can capture data from every nook and cranny of the human body. An electrode that reads brain signals in Parkinson’s patients. A tattoo-like patch to detect skin cancer. And now, a bra containing a flexible ultrasound that could one day be used to more comfortably screen for breast cancer.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Healthcare
JULY 28, 2023
Lobbying groups representing different camps of the healthcare industry have come together to urge the Centers for Medicare & Medicaid Service (CMS) to reconsider “conflicting regulatory propos | The American Hospital Association, American Medical Association and Blue Cross Blue Shield Association penned a joint letter highlighting "conflicting" prior authorization electronic standards and workflows they say will bring industry confusion and unnecessary burden.
Drug Topics
JULY 28, 2023
A recent study determined over 12,000 screenings would need to be done to identify 1 case of melanoma in racial and ethnic minority populations.
Pharmacy Times
JULY 28, 2023
Pharmacists play a key role in migraine management, therefore, awareness of menstrual migraine-specific prophylaxis is important.
pharmaphorum
JULY 28, 2023
After cutbacks, Biogen adds new drug with $7.3bn Reata buy Phil.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
JULY 28, 2023
The time is now 90 seconds to midnight, according to the Doomsday Clock, which scientists use to estimate how close humanity might be to blowing itself up with nuclear weapons. | The world hasn't been this close to nuclear war since the Cold War, say experts. Editors of prestigious medical journals sound a call to disarm.
Drug Topics
JULY 28, 2023
Demetre Daskalakis, MD, MPH, urged those in the LGBTQ+ community to get fully vaccinated against the disease.
Pharmacy Times
JULY 27, 2023
Further analysis shows that 300 mg lenacapvir tablets plus an optimized background regimen can effectively reconcile a missed dose of lenacapavir injection in patients with HIV.
The Checkup by Singlecare
JULY 28, 2023
When your healthcare provider places the blood pressure cuff around your arm, you likely hope you won’t have high blood pressure. Hypertension is a common medical condition, but did you know there’s also a possibility your blood pressure could be too low? Turns out, a lot can be revealed as that cuff tightens around your biceps. Blood pressure is a measure of heart and vascular health, specifically the force of blood force flowing through blood vessels.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Drug Store News
JULY 28, 2023
​​​​​​​Rite Aid shared its progress across its four key pillars, focused on areas such as environmental sustainability, responsible sourcing, employee benefits and more.
Drug Topics
JULY 28, 2023
According to the CDC, HPV is the most commonly sexually transmitted infection in the US, with a prevalence of 45.2% of men and 39.9% of women aged 18-59 in 2013-2014.
Pharmacy Times
JULY 27, 2023
Consuming a vegetarian diet lowered LDL-C, HbA1C, and body weight when compared to a usual diet, but did not significantly affect systolic blood pressure levels.
European Pharmaceutical Review
JULY 28, 2023
Publication of results of the Phase III SKYLARK study “is a pinnacle moment in treating postpartum depression ( PDD ),” stated Dr Kristina M Deligiannidis, Professor at the Institute of Behavioral Science at the Feinstein Institutes, the trial’s principal investigator, lead author of the paper. The study investigated oral 50mg, 14-day neuroactive steroid zuranolone pill as a treatment for perinatal or postpartum depression.
Fierce Healthcare
JULY 27, 2023
Last month, the American Medical Association (AMA) passed a resolution to protect access to gender-affirming care, committing to opposing criminal and legal penalties against patients, their famili | Approved by Gov. Ron DeSantis, the law imposes restrictions on adult access to gender-affirming care. Some providers have been forced to stop serving new or existing patients in some capacity.
Drug Topics
JULY 27, 2023
A new study found that 25%-46% of esophageal adenocarcinomas in patients with newly diagnosed Barrett’s esophagus were categorized as post-endoscopy esophageal adenocarcinoma.
Pharmacy Times
JULY 27, 2023
The risk could double if the conditions are met, with deaths more common in women and those aged 80 and older.
STAT
JULY 27, 2023
For many Americans, the warmer spring and summer months bring backyard barbecues and scenic hikes — along with a chorus of cicadas, mosquitoes galore, and hypervigilant self-checks for ticks. Often, insect bites only cause mild discomfort but new reports from the Centers for Disease Control and Prevention warn that a food allergy caused by ticks is on the rise in the U.S.
Fierce Pharma
JULY 27, 2023
To Roche’s pharma chief Teresa Graham, no word better describes the company’s eye drug Vabysmo right now than “momentum.” | To Roche’s pharma chief Teresa Graham, no word better describes the company’s eye drug Vabysmo right now than “momentum.” Approved by the FDA in January 2022, Vabysmo already crossed the one-billion-dollar sales mark in the first half of 2023.
Drug Topics
JULY 27, 2023
The National Rosacea Society found that a lack of health insurance or the high cost of a copay caused 52% of respondents to avoid obtaining medical care for their rosacea.
Pharmacy Times
JULY 27, 2023
A study shows the first 2 years of life are a vital time to establish healthy sleep routines in infant children.
STAT
JULY 27, 2023
The handling of Senate Minority Leader Mitch McConnell’s abrupt medical issue this week is raising concerns among medical experts that the event sent a potentially dangerous public-health message — that when someone experiences an episode with symptoms like McConnell’s, they can simply return to work as though nothing had happened.
Fierce Pharma
JULY 27, 2023
Eli Lilly continues to bolster the case for its dual GIP/GLP-1 agonist tirzepatide as a powerful weight loss agent. | Also known as Mounjaro in its approved type 2 diabetes indication, tirzepatide helped patients across two trials—Surmount-3 and Surmount-4—lose up to 26.6% of their body weight, Lilly said Thursday.
Drug Topics
JULY 27, 2023
A minimum dose of 3.4 to 3.6 minutes of vigorous intermittent lifestyle physical activity per day was associated with a 17% to 18% reduction in total incident cancer risk.
Pharmacy Times
JULY 27, 2023
Rates of hospitalizations and mortality from COVID-19 were more than 4 times lower in 2022 compared to 2021, as the virus become less severe with new mutations, a recent study found.
Expert insights. Personalized for you.
187 
Let's personalize your content